Antigen-Specific Regulatory T Cells and Low Dose of IL-2 in Treatment of Type 1 Diabetes

    January 2016 in “ Frontiers in immunology
    Minh N. Pham, Matthias G. von Herrath, José Luis Vela
    New to Alopecia Areata? There is a guide in the encyclopedia. Read the guide →
    Studysummary This review discusses the potential of combining low-dose IL-2 with islet antigens to enhance antigen-specific Treg function in type 1 diabetes, but reports no new clinical results.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Discuss this study in the Community →

    Research cited in this study

    2 / 2 results